This flu season is bad compared to recent years. But it’s not just flu. Thankfully, we are not seeing significant increases in COVID rates.
This may be hard to believe, but the first human infection with SARS-CoV2, probably occurred right around now, three years ago.
The impact of COVID continues to decline with 80% of US counties in the CDC “Green” level and only just over 2% remaining in the “Red” level.
We are expecting to see the current low levels of flu activity will end and we will start to see the typical early signs of flu season.
Today is the first full day of fall, which is also the typical beginning of cold and flu season, and potentially COVID resurgence season.
The biggest news this week is the authorization and distribution of the new “bivalent” vaccine for COVID-19.
The FDA formally authorized (EUA) updated COVID-19 boosters this week. We recommend that anyone who is eligible for this booster should get it.
While still a little too soon to say Monkeypox is on its way out, the peak in cases appears to have occurred about 3 weeks ago
Globally, there are about 38,000 cases of Monkeypox, in Europe there are roughly 19,000 cases and in the US there are nearly 13,000.
It is important to keep a couple of comparisons between COVID and Monkeypox in mind as you process the news about Monkeypox.